AAWHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Ascend Wellness Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.39−0.00 (-0.73%)
Close on Oct 19, 2026
- Market cap
- $79.60M
- P/E (TTM)
- –
- Dividend yield
- –
Ascend Wellness Holdings, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Retail revenue | $344.60M | $338.34M | $339.56M | $344.95M | $354.77M | $361.38M | $372.24M | $379.19M | $386.86M | $383.63M | $371.17M | $358.16M | 70.6% | -2.9% |
| Third-party wholesale revenue | $143.73M | $151.18M | $161.02M | $171.09M | $178.19M | $185.80M | $189.36M | – | – | – | – | – | 29.4% | -19.3% |
| Wholesale revenue | – | – | – | – | – | – | – | $312.24M | $303.02M | $284.61M | $264.07M | $238.50M | – | – |
By region
From the segment and revenue-disaggregation notes of Ascend Wellness's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.